Autoantibodies Directed to Deamidated Post-translationally Modified IA-2 Epitopes in Type 1 Diabetes | American Diabetes Association

Autoantibodies Directed to Deamidated Post-translationally Modified IA-2 Epitopes in Type 1 Diabetes

Speaker: Massimo Pietropaolo
Session: New Insights into Immunomodulatory Therapies and Biomarkers of Autoimmune Disorder (With State-of-the-Art Lecture)
Congress: 79th Scientific Sessions